Skip to content

To investigate the impact and underlying mechanisms of cell senescence on the progression of bladder cancer using multi-omics approaches

To investigate the impact and underlying mechanisms of cell senescence on the progression of bladder cancer using multi-omics approaches

Status
Active, not recruiting
Phases
Unknown
Study type
Observational
Source
ChiCTR
Registry ID
ChiCTR2500100621
Enrollment
Unknown
Registered
2025-04-11
Start date
2025-04-18
Completion date
Unknown
Last updated
2025-04-14

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Bladder cancer

Interventions

Normal group,:None. Only specimens and clinical data were taken
Tumor group:None. Clinical data and pathological sections of the patients

Sponsors

The Second Affiliated Hospital of Shandong First Medical University
Lead Sponsor

Eligibility

Sex/Gender
All
Age
18 Years to 90 Years

Inclusion criteria

Inclusion criteria: (1) All patients were diagnosed as urothelial carcinoma by diagnostic transurethral resection; (2) All patients underwent chemotherapy and surgery in our center with complete clinical data;

Exclusion criteria

Exclusion criteria: (1) The presence of other histological differentiation such as squamous cell carcinoma, adenocarcinoma, sarcoma, etc.; (2) receiving radiotherapy and anti-tumor therapy (chemoradiotherapy, immunotherapy, etc.) before admission; (3) patients with other tumors or serious underlying diseases who could not tolerate surgery. (4) patients with incomplete clinical data.or serious underlying diseases who cannot tolerate surgery. (5) patients with incomplete clinical data.

Design outcomes

Primary

MeasureTime frame
The main character gene;

Countries

China

Contacts

Public ContactLinlin Zhang

The Second Affiliated Hospital of Shandong First Medical University

zhanglinlin-321@163.com+86 188 5388 6298

Outcome results

None listed

Source: ChiCTR (via WHO ICTRP) · Data processed: Feb 4, 2026